Related Experiment Video
Updated: Aug 24, 2025
11:00
Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing
Published on: November 29, 2018
14.4K
Recent advances in organotypic tissue slice cultures for anticancer drug development
Lin He1,2,3, Chuxia Deng1,2,3
1Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China.
International Journal of Biological Sciences
|October 20, 2022
Summary
Organotypic tissue slice culture aids anticancer drug development by preserving tissue components and predicting treatment responses. This method is key for personalized medicine and future anticancer drug screening.
Area of Science:
- Oncology
- Biotechnology
- Pharmacology
Background:
- Organotypic tissue slice culture involves cultivating animal or patient tissues in an in vitro ecosystem.
- This technique offers numerous advantages for anticancer drug development.
Purpose of the Study:
- To highlight the contributions and advantages of organotypic tissue slice culture in anticancer drug development.
- To emphasize its role in personalized medicine and future drug screening.
Main Methods:
- Establishing organotypic tissue slice cultures from animal or patient tissues.
- Utilizing these cultures for in vitro studies.
Main Results:
- Preservation of cell repertoire and immune components.
- Identification of tumor invasive ability and compound toxicity.
- Rapid assessment of therapeutic efficacy with high predictive performance for drug responses.
Conclusions:
- Organotypic tissue slice culture is a reliable tool for stratifying therapeutic responders and nonresponders.
- It aids in selecting optimal treatment regimens for personalized medicine.
- This technique is poised to become a gold standard for individualized anticancer drug screening.
